Skip to Main Content

Author Details

Pardeep Kaurah
University of British Columbia
1992
32
22
PMIDPaper TitleJournal TitlePublished Year
35621648Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic.Curr Oncol2022
35621648Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic.Curr Oncol2022
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
33797756Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.J Pathol2021
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
33797756Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.J Pathol2021
32489267Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.Curr Oncol2020
32489267Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.Curr Oncol2020
32758476Hereditary diffuse gastric cancer: updated clinical practice guidelines.Lancet Oncol2020
32758476Hereditary diffuse gastric cancer: updated clinical practice guidelines.Lancet Oncol2020
31200828Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.Lung Cancer2019
31200828Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.Lung Cancer2019
30311375Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.Hum Mutat2018
30311375Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.Hum Mutat2018
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
25979631Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.J Med Genet2015
26182300Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.JAMA Oncol2015
25979631Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.J Med Genet2015
26182300Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.JAMA Oncol2015
25340522Germline mutations in MAP3K6 are associated with familial gastric cancer.PLoS Genet2014
25340522Germline mutations in MAP3K6 are associated with familial gastric cancer.PLoS Genet2014
21813476Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.Gut2012
23071139Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.Cancer Epidemiol Biomarkers Prev2012
21813476Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.Gut2012
23071139Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.Cancer Epidemiol Biomarkers Prev2012
20921021Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.J Med Genet2011
20931355Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.J Genet Couns2011
20921021Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.J Med Genet2011
20931355Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.J Genet Couns2011
20063069Pregnancy after prophylactic total gastrectomy.Fam Cancer2010
20063069Pregnancy after prophylactic total gastrectomy.Fam Cancer2010
19269290Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.Gastroenterology2009
19269290Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.Gastroenterology2009
19408054Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.Ann Surg Oncol2009
19168852Germline CDH1 deletions in hereditary diffuse gastric cancer families.Hum Mol Genet2009
19408054Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.Ann Surg Oncol2009
19168852Germline CDH1 deletions in hereditary diffuse gastric cancer families.Hum Mol Genet2009
18046629Hereditary diffuse gastric cancer: association with lobular breast cancer.Fam Cancer2008
18046629Hereditary diffuse gastric cancer: association with lobular breast cancer.Fam Cancer2008
18442100Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.Cancer2008
18208621Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.BMC Cancer2008
18208621Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.BMC Cancer2008
18442100Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.Cancer2008
17660459Germline E-cadherin mutations in familial lobular breast cancer.J Med Genet2007
17660459Germline E-cadherin mutations in familial lobular breast cancer.J Med Genet2007
17545690Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA2007
17955726[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene].Acta Gastroenterol Latinoam2007
17955726[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene].Acta Gastroenterol Latinoam2007
17545690Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA2007
  • 1 - 50 of 64

Recommended Authors

Zerin Hyder
University of Manchester
Career Start Year 2017
Number of shared co-authors 0
Nicholas Pachter
King Edward Memorial Hospital
Career Start Year 2009
Number of shared co-authors 11
Richard H Scott
Great Ormond Street Hospital
Career Start Year 2006
Number of shared co-authors 1
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 1
Teresa Ram??n y Cajal
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 23
Paul Brennan
Newcastle Hospitals NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 1
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Career Start Year 1998
Number of shared co-authors 33
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 25
Edward D Esplin
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 4
Ian D Krantz
Children's Hospital of Philadelphia
Career Start Year 1996
Number of shared co-authors 6
Tom Walsh
University of Washington
Career Start Year 1996
Number of shared co-authors 20
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 1993
Number of shared co-authors 25
Patrick J Morrison
Belfast City Hospital
Career Start Year 1989
Number of shared co-authors 17
Lawrence C Brody
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 12
Ming K Lee
University of Washington
Career Start Year 1988
Number of shared co-authors 13
Leslie G Biesecker
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 14
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 25
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 32
Georgia L Wiesner
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 9
Ilse Wieland
Institute of Human Genetics, University Hospital Magdeburg
Career Start Year 1985
Number of shared co-authors 0
Nancy B Spinner
The Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1984
Number of shared co-authors 6
Arupa Ganguly
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 1
Douglas F Easton
University of Cambridge
Career Start Year 1982
Number of shared co-authors 37
Claude Houdayer
INSERM U1245
Career Start Year 1981
Number of shared co-authors 18
Jan Lubinski
Pomeranian Medical University
Career Start Year 1979
Number of shared co-authors 39
Stephen N Thibodeau
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 23
Javier Ben??tez
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 34
Mary-Claire King
University of Washington
Career Start Year 1975
Number of shared co-authors 20
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 31
Albert de la Chapelle
The Ohio State University Comprehensive Cancer Center
Career Start Year 1961
Number of shared co-authors 11

Collaborators

David G Huntsman
University of British Columbia
Co-authored papers 25
Janine Senz
University of British Columbia
Co-authored papers 13
Carla Oliveira
Co-authored papers 10
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 8
Kasmintan A Schrader
University of British Columbia
Co-authored papers 7
James M Ford
Stanford University
Co-authored papers 6
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 4
Xiaogang Wen
Centro Hospitalar Universitario do Porto (CHUP).
Co-authored papers 4
Scott M Weissman
Center for Medical Genetics, NorthShore University HealthSystem
Co-authored papers 4
Wendy S Rubinstein
CancerLinQ LLC, American Society of Clinical Oncology
Co-authored papers 3
Bridget A Fernandez
Memorial University of Newfoundland
Co-authored papers 3
Alex Boussioutas
Royal Melbourne Hospital, University of Melbourne
Co-authored papers 3
Samantha Hansford
The University of British Columbia
Co-authored papers 3
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 3
Noralane M Lindor
Mayo Clinic
Co-authored papers 3
Kerry Phillips
Royal Adelaide Hospital
Co-authored papers 2
Sylviane Olschwang
Aix Marseille Universite, INSERM GMGF UMR 1
Co-authored papers 2
Graeme Suthers
University of Adelaide
Co-authored papers 2
Angela Brooks-Wilson
Co-authored papers 2
Florian Grimpen
Royal Brisbane and Women's Hospital
Co-authored papers 2
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 2
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Yaron S Butterfield
Brain Tumour Foundation of Canada
Co-authored papers 2
Andrew D Clouston
University of Queensland
Co-authored papers 2
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Steve E Kalloger
University of British Columbia
Co-authored papers 2
Nicola Wayte
The Queensland Institute of Medical Research
Co-authored papers 2
Daniel L Worthley
South Australian Health and Medical Research Institute
Co-authored papers 2
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Release 1.2